Health
Could heparin-based therapies be a viable treatment for COVID-19? – The Science Board
Researchers have identified a novel approach to treating SARS-CoV-2 infection, spurred by a new understanding of viral attachment involving a heparan sulfate, a common glycoprotein. The results are presented in a September 14 article published in Cell
Some viruses interact with heparan sulfate, a highly negatively charged linear polysaccharide that is attached to a small set of membrane or extracellular matrix proteoglycans. In this format, glycan-binding domains on membrane proteins facilitate initial attachment of virions to glycan receptors, leading to eventual virus engulfment and internalization.
Trimeric spike proteins of SARS-CoV-2 engage human angiotensin-converting enzyme 2 (ACE2) with one or more receptor binding domains (RBD) in t…
-
Noosa News16 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General14 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News15 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Business17 hours agoSolid superannuation gains continue to roll in